Jci_page_head_homepage_01 Jci_page_head_homepage_02
Balasubramanian Krishnamurthy, Nadine L. Dudek, Mark D. McKenzie, Anthony W. Purcell, Andrew G. Brooks, Shane Gellert, Peter G. Colman, Leonard C. Harrison, Andrew M. Lew, Helen E. Thomas, Thomas W.H. Kay
Published in Volume 116, Issue 12
J Clin Invest. 2006; 116(12):3258–3265 doi:10.1172/JCI29602
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
T cell responses in NOD and NOD-PI mice after immunization with IGRP206–214 peptide.

NOD and NOD-PI mice were primed with 25 μg of IGRP206–214 peptide in CFA (n = 4) or with CFA alone (n = 2). After 1 week, splenocytes were collected and cultured with 106 1500-cGy-irradiated IGRP206–214 loaded NOD splenocytes in complete RPMI supplemented with 10 U/ml rhIL-2 for 6 days. A sample of cultured cells was stained with IGRP206–214 tetramer and analyzed by flow cytometry and the remainder used as effectors in a cytotoxicity assay. (A) IGRP206–214 tetramer–positive CD8+ T cells from spleens of NOD and NOD-PI mice immunized with IGRP206–214 peptide in CFA or with CFA alone. (B) IGRP206–214-specific CD8+ T cells from spleens of NOD-PI mice following priming with IGRP206–214 peptide in CFA were cytotoxic, as assessed by a standard 4-hour 51Cr release assay.